Cardiovascular Drugs Global Market Size, Share, Industry

The global anti-infective drugs market report by the business research company identifies a flipped classroom model of teaching by enhancing the students learning experience by creating an interactive atmosphere in classrooms. In a flipped classroom, students view lecture materials or video lectures as homework before coming to class. In-class time, interactive discussions, and collaborative works are performed under the guidance of a teacher. Flipped classroom gives students the flexibility to consume the lecture material at their own pace and come prepared to ask specific questions in class. For instance, according to the Flipped Learning Network, 71% of teachers who flipped their classes noticed improved grades, and 80% reported improved student behavior as a result, thus indicating the effectiveness of the flipped classroom teaching model. Some of the educational service providers using flipped classrooms to teach students include the University of California, Clemson University, Boston University, Harvard University, University of Michigan, and Texila American University.

The global anti-infective drugs market size is expected to decline from $220.0 billion in 2021 to $246.80 billion in 2022 at a compound annual growth rate (CAGR) of 12.2%. The change in the anti-infective drugs market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The anti-infective drugs market is expected to reach $614.29 billion in 2026 at a CAGR of 25.6%.

Purchase The Anti-Infective Drugs Market Report Here:

North America was the largest region in the anti-infective drug in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Major players in the anti-infective drug market are Gilead Sciences, GlaxosmithKline, Merck & Co, Johnson & Johnson, Pfizer Inc., AbbVie, Bayer AG, Mylan NV, Shionogi and F. Hoffmann-La Roche Ltd.

The global anti-infective drugs market is segmented –
1) By Type: Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
3) By Route of Administration: Oral, Parental, Others
4) By Drug Classification: Branded Drugs, Generic Drugs
5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

Request A Sample Of The Anti-Infective Drugs Market Report Here:

The Anti-Infective Drugs Market Report Contents Include
1.Executive Summary
2. Report Structure
3. Anti-Infective Drugs Market Characteristics
4. Anti-Infective Drugs Market Product Analysis
5. Anti-Infective Drugs Market Supply Chain
21. Key Mergers And Acquisitions In The Anti-Infective Drugs Market
22. Market Background: Pharmaceutical Drugs Market
23. Recommendations
24. Appendix
25. Copyright And Disclaimer

This report covers the trends and market dynamics of the anti-infective drug market in major countries – Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Check out our:
TBRC Blog:
Global Market Model:
Healthcare Blog:

About Us:
The Business Research Company ( is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

This release was published on openPR.


Leave a Comment